Histone Modifications and Cancer

被引:764
作者
Audia, James E. [1 ]
Campbell, Robert M. [2 ]
机构
[1] Constellat Pharmaceut, Cambridge, MA 02142 USA
[2] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
基金
美国国家卫生研究院;
关键词
CELL-CYCLE PROGRESSION; ARGININE METHYLTRANSFERASE 5; ESTROGEN-RECEPTOR-ALPHA; GROUP PROTEINS RING1A/B; TUMOR-SUPPRESSOR; COLORECTAL-CANCER; SWI/SNF COMPLEXES; CLASS-I; LYSINE METHYLTRANSFERASE; CHROMATIN MODIFICATIONS;
D O I
10.1101/cshperspect.a019521
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Histone posttranslational modifications represent a versatile set of epigenetic marks involved not only in dynamic cellular processes, such as transcription and DNA repair, but also in the stable maintenance of repressive chromatin. In this article, we review many of the key and newly identified histone modifications known to be deregulated in cancer and how this impacts function. The latter part of the article addresses the challenges and current status of the epigenetic drug development process as it applies to cancer therapeutics.
引用
收藏
页数:31
相关论文
共 232 条
[81]
Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2 [J].
Helias, Catherine ;
Struski, Stephanie ;
Gervais, Carine ;
Leymarie, Vincent ;
Mauvieux, Laurent ;
Herbrecht, Raoul ;
Lessard, Michel .
CANCER GENETICS AND CYTOGENETICS, 2008, 180 (01) :51-55
[82]
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3 (Retracted article. See vol. 63, pg. 180, 2016) [J].
Herranz, Nicolas ;
Dave, Natalia ;
Millanes-Romero, Alba ;
Morey, Lluis ;
Diaz, Victor M. ;
Lorenz-Fonfria, Victor ;
Gutierrez-Gallego, Ricardo ;
Jeronimo, Celia ;
Di Croce, Luciano ;
Garcia de Herreros, Antonio ;
Peiro, Sandra .
MOLECULAR CELL, 2012, 46 (03) :369-376
[83]
Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin [J].
Hirota, T ;
Lipp, JJ ;
Toh, BH ;
Peters, JM .
NATURE, 2005, 438 (7071) :1176-1180
[84]
The role of histone demethylases in cancer therapy [J].
Hoffmann, Inga ;
Roatsch, Martin ;
Schmitt, Martin L. ;
Carlino, Luca ;
Pippel, Martin ;
Sippl, Wolfgang ;
Jung, Manfred .
MOLECULAR ONCOLOGY, 2012, 6 (06) :683-703
[85]
High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers [J].
Hou, X. ;
Li, Y. ;
Luo, R. -Z. ;
Fu, J. -H. ;
He, J. -H. ;
Zhang, L. -J. ;
Yang, H. -X. .
EJSO, 2012, 38 (06) :523-530
[86]
Sirtuins as regulators of metabolism and healthspan [J].
Houtkooper, Riekelt H. ;
Pirinen, Eija ;
Auwerx, Johan .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (04) :225-238
[87]
KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation [J].
Hsia, Datsun A. ;
Tepper, Clifford G. ;
Pochampalli, Mamata R. ;
Hsia, Elaine Y. C. ;
Izumiya, Chie ;
Huerta, Steve B. ;
Wright, Michael E. ;
Chen, Hong-Wu ;
Kung, Hsing-Jien ;
Izumiya, Yoshihiro .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (21) :9671-9676
[88]
Histone H4 deacetylation facilitates 53BP1 DNA damage signaling and double-strand break repair [J].
Hsiao, Kuei-Yang ;
Mizzen, Craig A. .
JOURNAL OF MOLECULAR CELL BIOLOGY, 2013, 5 (03) :157-165
[89]
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo [J].
Hu, Sha ;
Yu, Lili ;
Li, Zhimin ;
Shen, Yi ;
Wang, Jing ;
Cai, Jing ;
Xiao, Lan ;
Wang, Zehua .
CANCER BIOLOGY & THERAPY, 2010, 10 (08) :788-795
[90]
Repression of p53 activity by Smyd2-mediated methylation [J].
Huang, Jing ;
Perez-Burgos, Laura ;
Placek, Brandon J. ;
Sengupta, Roopsha ;
Richter, Mario ;
Dorsey, Jean A. ;
Kubicek, Stefan ;
Opravil, Susanne ;
Jenuwein, Thomas ;
Berger, Shelley L. .
NATURE, 2006, 444 (7119) :629-632